<DOC>
	<DOC>NCT00903240</DOC>
	<brief_summary>The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine</brief_summary>
	<brief_title>Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Intact bladder Scheduled for cystoscopy for transitional cell bladder cancer recurrence screening Urine donated prior to cystoscopy, Bladder biopsy, chemotherapy, intravesical therapy, radiation or TUR Must be willing to sign IRB approved informed consent History or current diagnosis of any cancer except transitional cell bladder cancer or basal cell cancer Known diagnosis of any autoimmune disease or HIV, HCV or HBV History or current TB or any other active infection Subject has gross hematuria Receiving chemotherapy, intravesical therapy or radiation within 30 days of enrollment Any surgery except urologic within past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>